Check Out Noetica’s Q3’25 Radar Report Here
Products +
Legal Solutions
Noetica empowers transactional attorneys with term-level analytics—understand how your terms compare to the entire market.
Table listing key terms and their ratings for Acadia Healthcare Term Loan and Revolving Credit Facility, including restricted payment ratios and debt classifications.
Financial Solutions
Noetica empowers capital markets and M&A attorneys to analyze complex transactions.
Customers +
Noetica financial analysis interface showing Market Prevalence Score of 85% for Redwood Industries, with filters for sector, market cap, and public/private status.
Transactional Attorneys
Dashboard interface showing Noetica logo and navigation with graphs for Deals Per Year from 2020 to 2024 and Monthly Trends below.
Knowledge Management & Innovation
Dashboard showing Restricted Payment Ratio with a market comparison bar chart and a market trend line chart over four quarters.
Investment Professionals
Media +
Media Hub
News
Market Insights
Reports & Trends
Media Hub
News
Market Insights
Reports & Trends
Company +
About Us
Careers
Noetica team photo
About Us
Careers
Join UsBook a Demo
Book a Demo
Media Hub
Market Insights
Post
Market Insights
October 2024

EBITDA is a state of mind

Uncapped cost-savings addbacks are out, but borrowers are still getting creative with generous caps and long look-forward windows.
Dan Wertman
Dan Wertman

"𝙐𝙣𝙘𝙖𝙥𝙥𝙚𝙙" is the holy grail for borrowers—not so much for lenders.

Manipulation of EBITDA through cost savings addbacks can increase a borrower’s ability to incur priming debt, move assets from the credit group via dividends or asset transfers, or even avoid an event of default under a financial covenant.

While uncapped addbacks remain relatively rare, high caps and long look-forward periods still provide significant flexibility for borrowers. In the third quarter of 2024, 34% of publicly filed high yield credit agreements permitted cost savings-based addbacks to EBITDA, compared to only 20% of such deals in the same period in 2023.

Of deals allowing such add-backs, none permitted uncapped addbacks in Q3 2024, compared to 3% in Q3 2023.

However, in Q3 2024, 78% of deals permitting cost savings addbacks included caps equal to or greater than 20% of EBITDA, compared to 53% of such deals in Q3 2023. In addition, 17% of such deals in Q3 2024 included a look-forward period of 24 months or greater, compared to 47% of Q3 2023.

No alternative text description for this image

Message me if you’d like access to the deal data underlying the EBITDA addbacks.

‍

suggested reads
Media Hub
Bloomberg
News
October 2025

AI Scours 1 Billion Deal Terms to Show Lenders' Default Defenses

Bloomberg exclusively featured Noetica's Q3 capital markets data in their latest market intelligence.
News
November 2025

Private credit is shifting to larger cap deals

CNBC featured Noetica’s Q3 analytics, highlighting how clauses inside credit agreements are signaling investor sentiment and reshaping how markets assess risk.
The Wall Street Journal
News
October 2025

A Private-Credit Winter Is Coming

The Wall Street Journal published Noetica's insights on how shifts inside credit agreements are signaling deeper cracks in the market.
Next
The Wall Street Journal
News
October 2025

A Private-Credit Winter Is Coming

The Wall Street Journal published Noetica's insights on how shifts inside credit agreements are signaling deeper cracks in the market.
Previous
Book a demo

See Noetica in Action

Book a personalized demo to see how Noetica’s AI-powered platform helps legal and financial teams unlock better insights and drive faster deals.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
New York, NY 10017
contact@noetica.ai
Product
LegalFinancial
Customers
Transactional AttorneysKnowledge Management & InnovationInvestment Professionals
Media
Media HubNewsMarket InsightsReports & Trends
cOMPANY
AboutCareersBook a Demo
© 2025 Noetica Inc. All rights reserved.
Privacy PolicyTerms of ServiceCookies Settings

By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

PreferencesRejectAccept
Manage Consent Preferences by Category
Essentials
Always active

Necessary for the site to function. Always On.

Used for targeted advertising.

Remembers your preferences and provides enhanced features.

Measures usage and improves your experience.

Reject AllAccept All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.